Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:alpha-D-galactose
go back to main search page
Accession:CHEBI:28061 term browser browse the term
Definition:D-Galactopyranose having alpha-configuration at the anomeric centre.
Synonyms:exact_synonym: alpha-D-galactopyranose
 related_synonym: Formula=C6H12O6;   Gal-alpha;   InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1;   InChIKey=WQZGKKKJIJFFOK-PHYPRBDBSA-N;   SMILES=OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O;   WURCS=2.0/1,1,0/[a2112h-1a_1-5]/1/;   alpha-D-Gal
 alt_id: CHEBI:10231;   CHEBI:22373;   CHEBI:42741
 xref: Beilstein:1281609;   CAS:26566-61-0;   CAS:3646-73-9;   CAS:59-23-4;   Drug_Central:1271;   GlyGen:G09546QO;   GlyTouCan:G09546QO;   Gmelin:648638;   KEGG:C00984;   KEGG:C01582;   KEGG:D04291;   KNApSAcK:C00001119
 xref_mesh: MESH:D005690
 xref: PDBeChem:GLA;   PMID:17991151;   PMID:19443021;   PMID:25568069;   PMID:31537530;   PMID:7521740;   PMID:8154046;   Reaxys:1281609
 cyclic_relationship: is_enantiomer_of CHEBI:42905


show annotations for term's descendants           Sort by:
alpha-D-galactose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase (Yt blood group) increases activity
multiple interactions		 ISO Galactose results in increased activity of ACHE protein
catalpol inhibits the reaction [Galactose results in increased activity of ACHE protein]; theaflavin-3,3'-digallate inhibits the reaction [Galactose results in increased activity of ACHE protein]		 CTD PMID:23612000 PMID:36638877 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974 		JBrowse link
G AGER advanced glycosylation end-product specific receptor increases expression
multiple interactions
decreases expression		 ISO Galactose results in increased expression of AGER mRNA; Galactose results in increased expression of AGER protein
agomelatine inhibits the reaction [Galactose results in increased expression of AGER protein]
Galactose results in decreased expression of AGER protein
[Ethanol co-treated with Galactose] results in decreased expression of AGER protein		 CTD PMID:22687555 PMID:33516661 PMID:34673010 NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322 		JBrowse link
G AIF1 allograft inflammatory factor 1 multiple interactions
increases expression		 ISO lycopene inhibits the reaction [Galactose results in increased expression of AIF1 protein]
agomelatine inhibits the reaction [Galactose results in increased expression of AIF1 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of AIF1 protein]		 CTD PMID:28974442 PMID:34673010 NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021 		JBrowse link
G AKR1B1 aldo-keto reductase family 1 member B increases expression
multiple interactions		 ISO Galactose results in increased expression of AKR1B1 mRNA
protocatechuic acid inhibits the reaction [Galactose results in increased expression of AKR1B1 mRNA]		 CTD PMID:22687555 NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284 		JBrowse link
G AOX1 aldehyde oxidase 1 increases expression
multiple interactions		 EXP Galactose results in increased expression of AOX1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in increased expression of AOX1 mRNA]		 CTD PMID:23274001 NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,586,014...200,677,064 		JBrowse link
G APP amyloid beta precursor protein multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in decreased expression of APP protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of APP protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of APP protein] CTD PMID:35537655 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128 		JBrowse link
G AQP4 aquaporin 4 multiple interactions ISO [Ethanol co-treated with Galactose] results in decreased expression of AQP4 protein CTD PMID:33516661 NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771 		JBrowse link
G ATF4 activating transcription factor 4 multiple interactions EXP [Galactose co-treated with Glucose deficiency] promotes the reaction [leflunomide results in increased expression of ATF4 protein] CTD PMID:29427785 NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683 		JBrowse link
G ATG5 autophagy related 5 decreases expression
multiple interactions		 ISO Galactose results in decreased expression of ATG5 mRNA
candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA]		 CTD PMID:34906534 NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791 		JBrowse link
G ATG7 autophagy related 7 decreases expression
multiple interactions		 ISO
EXP		 Galactose results in decreased expression of ATG7 protein
MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]		 CTD PMID:28302704 NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665 		JBrowse link
G ATOX1 antioxidant 1 copper chaperone decreases expression
multiple interactions		 EXP Galactose results in decreased expression of ATOX1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in decreased expression of ATOX1 mRNA]		 CTD PMID:23274001 NCBI chr 5:151,742,822...151,758,631
Ensembl chr 5:151,742,316...151,772,532 		JBrowse link
G ATP5F1A ATP synthase F1 subunit alpha multiple interactions ISO [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 NCBI chr18:46,080,248...46,104,227
Ensembl chr18:46,080,248...46,104,334 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions
increases expression		 EXP
ISO		 Phycocyanin inhibits the reaction [Galactose results in increased expression of BAX protein]
agomelatine inhibits the reaction [Galactose results in increased expression of BAX protein]; Galactose promotes the reaction [sodium arsenite results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [Galactose results in increased expression of BAX protein]; Saponins inhibits the reaction [Galactose results in increased expression of BAX protein]
Galactose results in increased expression of BAX mRNA; Galactose results in increased expression of BAX protein		 CTD PMID:23036742 PMID:25892055 PMID:34673010 PMID:35259467 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BCL2 BCL2 apoptosis regulator multiple interactions
decreases expression		 EXP
ISO		 Phycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein]
Galactose results in decreased expression of BCL2 mRNA; Galactose results in decreased expression of BCL2 protein
agomelatine inhibits the reaction [Galactose results in decreased expression of BCL2 protein]; Galactose promotes the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]; Melatonin inhibits the reaction [Galactose results in decreased expression of BCL2 protein]; Saponins inhibits the reaction [Galactose results in decreased expression of BCL2 protein]		 CTD PMID:23036742 PMID:25892055 PMID:34673010 PMID:35259467 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128 		JBrowse link
G BDNF brain derived neurotrophic factor decreases expression
multiple interactions		 ISO Galactose results in decreased expression of BDNF mRNA; Galactose results in decreased expression of BDNF protein
lycopene inhibits the reaction [Galactose results in decreased expression of BDNF mRNA]; lycopene inhibits the reaction [Galactose results in decreased expression of BDNF protein]		 CTD PMID:28974442 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058 		JBrowse link
G BECN1 beclin 1 multiple interactions
decreases expression		 ISO [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in decreased expression of BECN1 protein]; candesartan inhibits the reaction [Galactose results in decreased expression of BECN1 mRNA]
Galactose results in decreased expression of BECN1 mRNA; Galactose results in decreased expression of BECN1 protein		 CTD PMID:25997894 PMID:28302704 PMID:34906534 NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350 		JBrowse link
G CASP12 caspase 12 (gene/pseudogene) increases expression
multiple interactions		 ISO Galactose results in increased expression of CASP12 protein
agomelatine inhibits the reaction [Galactose results in increased expression of CASP12 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of CASP12 protein]		 CTD PMID:34673010 NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670 		JBrowse link
G CASP3 caspase 3 increases cleavage
increases expression
multiple interactions
increases activity		 EXP
ISO		 Galactose results in increased cleavage of CASP3 protein
Galactose results in increased expression of CASP3 mRNA
Galactose results in increased expression of CASP3 protein
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of CASP3 protein]
albicanol inhibits the reaction [Galactose results in increased expression of CASP3 mRNA]; Pioglitazone inhibits the reaction [Galactose results in increased activity of CASP3 protein]
Phycocyanin inhibits the reaction [Galactose results in increased cleavage of CASP3 protein]		 CTD PMID:23036742 PMID:23795773 PMID:25997894 PMID:32295448 PMID:33761044 More... NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CASP9 caspase 9 multiple interactions
increases expression		 ISO [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]
Galactose results in increased expression of CASP9 mRNA
albicanol inhibits the reaction [Galactose results in increased expression of CASP9 mRNA]
Galactose results in increased expression of CASP9 protein		 CTD PMID:25997894 PMID:32295448 PMID:33761044 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534 		JBrowse link
G CAT catalase multiple interactions
decreases activity
affects activity
increases activity		 ISO candesartan inhibits the reaction [Galactose results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Galactose results in increased activity of CAT protein]
Galactose affects the activity of CAT protein
[Galactose co-treated with Aluminum Chloride] results in decreased expression of CAT protein; albicanol inhibits the reaction [Galactose results in decreased activity of CAT protein]; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of CAT protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of CAT protein]		 CTD PMID:17211565 PMID:32295448 PMID:33761044 PMID:34906534 PMID:35537655 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CCN2 cellular communication network factor 2 increases expression
multiple interactions		 ISO Galactose results in increased expression of CCN2 protein
Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of CCN2 protein]		 CTD PMID:30367734 NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372 		JBrowse link
G CDH5 cadherin 5 decreases expression
multiple interactions		 ISO Galactose results in decreased expression of CDH5 protein
Ethanol promotes the reaction [Galactose results in decreased expression of CDH5 protein]		 CTD PMID:33516661 NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784 		JBrowse link
G CDK5R1 cyclin dependent kinase 5 regulatory subunit 1 increases expression
multiple interactions		 ISO Galactose results in increased expression of CDK5R1 protein
gentiopicroside analog inhibits the reaction [Galactose results in increased expression of CDK5R1 protein]		 CTD PMID:36878094 NCBI chr17:32,486,993...32,491,253
Ensembl chr17:32,486,993...32,491,253 		JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A increases expression
multiple interactions		 ISO Galactose results in increased expression of CDKN2A protein
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of CDKN2A protein]; Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of CDKN2A protein]]
agomelatine inhibits the reaction [Galactose results in increased expression of CDKN2A protein]; Melatonin inhibits the reaction [Galactose results in increased expression of CDKN2A protein]		 CTD PMID:34673010 PMID:36792013 NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301 		JBrowse link
G CHAT choline O-acetyltransferase multiple interactions
decreases activity		 ISO catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein] CTD PMID:23612000 NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942 		JBrowse link
G CHRM1 cholinergic receptor muscarinic 1 multiple interactions
decreases expression		 ISO catalpol inhibits the reaction [Galactose results in decreased expression of CHRM1 protein] CTD PMID:23612000 NCBI chr11:62,908,679...62,921,878
Ensembl chr11:62,908,679...62,921,807 		JBrowse link
G CTNNB1 catenin beta 1 multiple interactions
decreases expression		 ISO gentiopicroside analog inhibits the reaction [Galactose results in decreased expression of CTNNB1 protein] CTD PMID:36878094 NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases expression
multiple interactions		 EXP Galactose results in increased expression of CXCL8 mRNA
ginsenoside F1 inhibits the reaction [Galactose results in increased expression of CXCL8 mRNA]; ginsenoside F1 inhibits the reaction [Galactose results in increased secretion of CXCL8 protein]		 CTD PMID:29412148 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716 		JBrowse link
G CYBB cytochrome b-245 beta chain increases expression
multiple interactions		 ISO Galactose results in increased expression of CYBB protein
agomelatine inhibits the reaction [Galactose results in increased expression of CYBB protein]; Melatonin inhibits the reaction [Galactose results in increased expression of CYBB protein]		 CTD PMID:34673010 NCBI chr  X:37,780,059...37,813,461
Ensembl chr  X:37,780,018...37,813,461 		JBrowse link
G DDIT3 DNA damage inducible transcript 3 multiple interactions
increases expression		 EXP
ISO		 [Galactose co-treated with Glucose deficiency] promotes the reaction [leflunomide results in increased expression of DDIT3 protein]; Phycocyanin inhibits the reaction [Galactose results in increased expression of DDIT3 protein]
agomelatine inhibits the reaction [Galactose results in increased expression of DDIT3 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of DDIT3 protein]		 CTD PMID:23036742 PMID:29427785 PMID:34673010 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737 		JBrowse link
G DNM1L dynamin 1 like increases expression
multiple interactions		 EXP
ISO		 Galactose results in increased expression of DNM1L protein
MIR34A mRNA promotes the reaction [Galactose results in increased expression of DNM1L protein]		 CTD PMID:28302704 NCBI chr12:32,679,301...32,745,650
Ensembl chr12:32,679,200...32,745,650 		JBrowse link
G EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation		 ISO agomelatine inhibits the reaction [Galactose results in increased phosphorylation of EIF2AK3 protein]; Melatonin inhibits the reaction [Galactose results in increased phosphorylation of EIF2AK3 protein] CTD PMID:34673010 NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518 		JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 multiple interactions
increases phosphorylation		 ISO agomelatine inhibits the reaction [Galactose results in increased phosphorylation of ERN1 protein] CTD PMID:34673010 NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819 		JBrowse link
G FGF2 fibroblast growth factor 2 multiple interactions
increases expression		 ISO Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of FGF2 protein] CTD PMID:30367734 NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236 		JBrowse link
G GALK1 galactokinase 1 multiple interactions
increases metabolic processing		 EXP [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate CTD PMID:20696150 NCBI chr17:75,751,469...75,765,192
Ensembl chr17:75,751,594...75,765,236 		JBrowse link
G GAP43 growth associated protein 43 decreases expression
multiple interactions		 ISO Galactose results in decreased expression of GAP43 mRNA
Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA]		 CTD PMID:16707173 NCBI chr 3:115,623,510...115,721,483
Ensembl chr 3:115,623,510...115,721,490 		JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit decreases expression
multiple interactions		 ISO Galactose results in decreased expression of GCLC mRNA
Saponins inhibits the reaction [Galactose results in decreased expression of GCLC mRNA]		 CTD PMID:25892055 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970 		JBrowse link
G GDNF glial cell derived neurotrophic factor decreases expression
multiple interactions		 ISO Galactose results in decreased expression of GDNF mRNA
candesartan inhibits the reaction [Galactose results in decreased expression of GDNF mRNA]		 CTD PMID:34906534 NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041 		JBrowse link
G GFAP glial fibrillary acidic protein multiple interactions
increases expression		 ISO agomelatine inhibits the reaction [Galactose results in increased expression of GFAP protein]; Melatonin inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:34673010 NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937 		JBrowse link
G GLB1 galactosidase beta 1 multiple interactions
increases expression		 ISO (1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of GLB1 protein]; Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of GLB1 protein]] CTD PMID:36792013 NCBI chr 3:32,961,108...33,097,146
Ensembl chr 3:32,996,609...33,097,202 		JBrowse link
G GLO1 glyoxalase I multiple interactions ISO Galactose results in decreased expression of and results in decreased activity of GLO1 protein; protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] CTD PMID:22687555 NCBI chr 6:38,675,925...38,703,145
Ensembl chr 6:38,675,925...38,703,145 		JBrowse link
G GPT glutamic--pyruvic transaminase multiple interactions ISO [Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein] CTD PMID:34416243 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174 		JBrowse link
G GPX1 glutathione peroxidase 1 multiple interactions
decreases expression		 ISO theaflavin-3,3'-digallate inhibits the reaction [Galactose results in decreased expression of GPX1 mRNA] CTD PMID:36638877 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605 		JBrowse link
G GRIN1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions
increases expression		 ISO agomelatine inhibits the reaction [Galactose results in increased expression of GRIN1 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of GRIN1 protein] CTD PMID:34673010 NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756 		JBrowse link
G GRIN2B glutamate ionotropic receptor NMDA type subunit 2B increases expression
multiple interactions		 ISO Galactose results in increased expression of GRIN2B protein
agomelatine inhibits the reaction [Galactose results in increased expression of GRIN2B protein]; Melatonin inhibits the reaction [Galactose results in increased expression of GRIN2B protein]		 CTD PMID:34673010 NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002 		JBrowse link
G GSK3B glycogen synthase kinase 3 beta multiple interactions ISO Galactose results in increased expression of and results in decreased phosphorylation of GSK3B protein; gentiopicroside analog inhibits the reaction [Galactose results in increased expression of and results in decreased phosphorylation of GSK3B protein] CTD PMID:36878094 NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994 		JBrowse link
G GSS glutathione synthetase multiple interactions
decreases expression		 EXP sodium bisulfide inhibits the reaction [Galactose results in decreased expression of GSS mRNA] CTD PMID:23274001 NCBI chr20:34,928,432...34,956,027
Ensembl chr20:34,928,432...34,956,027 		JBrowse link
G HES1 hes family bHLH transcription factor 1 multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of HES1 protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of HES1 protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of HES1 protein] CTD PMID:35537655 NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732 		JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions EXP Galactose affects the reaction [Fusaric Acid affects the expression of HIF1A protein] CTD PMID:31654802 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259 		JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions
decreases expression		 ISO Saponins inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA]
albicanol inhibits the reaction [Galactose results in decreased expression of HMOX1 protein]; Lycopene inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA]		 CTD PMID:25892055 PMID:28974442 PMID:33761044 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214 		JBrowse link
G HSF1 heat shock transcription factor 1 increases activity EXP Galactose results in increased activity of HSF1 protein CTD PMID:34170685 NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720 		JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression		 EXP
ISO		 Phycocyanin inhibits the reaction [Galactose results in increased expression of HSPA5 protein]
Melatonin inhibits the reaction [Galactose results in increased expression of HSPA5 protein]		 CTD PMID:23036742 PMID:34673010 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382 		JBrowse link
G IFNB1 interferon beta 1 multiple interactions ISO [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased expression of IFNB1 protein; scoparone inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased expression of IFNB1 protein] CTD PMID:23535186 NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942 		JBrowse link
G IL10 interleukin 10 multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in decreased expression of IL10 protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of IL10 protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of IL10 protein] CTD PMID:35537655 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541 		JBrowse link
G IL1B interleukin 1 beta increases expression
multiple interactions
increases secretion		 ISO Galactose results in increased expression of IL1B mRNA; Galactose results in increased expression of IL1B protein
[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein; albicanol inhibits the reaction [Galactose results in increased expression of IL1B mRNA]; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein]; catalpol inhibits the reaction [Galactose results in increased expression of IL1B protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein]; Lycopene inhibits the reaction [Galactose results in increased expression of IL1B protein]; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL1B protein]		 CTD PMID:22687555 PMID:23612000 PMID:28974442 PMID:29405769 PMID:32295448 More... NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL6 interleukin 6 multiple interactions
increases expression
increases secretion		 ISO
EXP		 [Galactose co-treated with Aluminum Chloride] results in increased expression of IL6 protein; [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL6 protein; [Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL6 protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL6 protein]; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL6 protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL6 protein]
Galactose promotes the reaction [sodium arsenite results in increased expression of IL6 mRNA]
Galactose results in increased expression of IL6 mRNA; Galactose results in increased expression of IL6 protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside F1 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside M1 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rg3 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rh1 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rh2 inhibits the reaction [Galactose results in increased secretion of IL6 protein]		 CTD PMID:22687555 PMID:23535186 PMID:29412148 PMID:32295448 PMID:34416243 More... NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G IRF3 interferon regulatory factor 3 multiple interactions ISO [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased phosphorylation of IRF3 protein; scoparone inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased phosphorylation of IRF3 protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of IRF3 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IRF3 mRNA]		 CTD PMID:23535186 PMID:29405769 NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875 		JBrowse link
G ITPR3 inositol 1,4,5-trisphosphate receptor type 3 multiple interactions
increases expression		 ISO agomelatine inhibits the reaction [Galactose results in increased expression of ITPR3 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of ITPR3 protein] CTD PMID:34673010 NCBI chr 6:33,621,322...33,696,562
Ensembl chr 6:33,620,365...33,696,574 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] affects the localization of and results in increased expression of JUN protein modified form; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of JUN protein modified form] CTD PMID:23535186 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048 		JBrowse link
G KEAP1 kelch like ECH associated protein 1 multiple interactions
increases expression		 ISO albicanol inhibits the reaction [Galactose results in increased expression of KEAP1 mRNA]; albicanol inhibits the reaction [Galactose results in increased expression of KEAP1 protein]
Galactose results in increased expression of KEAP1 mRNA; Galactose results in increased expression of KEAP1 protein		 CTD PMID:33761044 NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558 		JBrowse link
G LCT lactase increases hydrolysis ISO LCT protein results in increased hydrolysis of Galactose CTD PMID:14701853 NCBI chr 2:135,787,850...135,837,184
Ensembl chr 2:135,787,850...135,837,184 		JBrowse link
G LRP1 LDL receptor related protein 1 decreases expression
multiple interactions		 ISO Galactose results in decreased expression of LRP1 protein
[Ethanol co-treated with Galactose] results in decreased expression of LRP1 protein		 CTD PMID:33516661 NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361 		JBrowse link
G LRP6 LDL receptor related protein 6 multiple interactions ISO [Galactose co-treated with gentiopicroside analog] results in increased expression of LRP6 protein CTD PMID:36878094 NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions
increases phosphorylation		 ISO Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased phosphorylation of MAPK1 protein] CTD PMID:30367734 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation		 ISO Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased phosphorylation of MAPK3 protein] CTD PMID:30367734 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MAPK8 mitogen-activated protein kinase 8 increases expression
multiple interactions		 ISO Galactose results in increased expression of MAPK8 mRNA
Galactose promotes the reaction [sodium arsenite results in increased expression of MAPK8 mRNA]		 CTD PMID:35259467 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360 		JBrowse link
G MAPT microtubule associated protein tau increases expression
multiple interactions		 ISO Galactose results in increased expression of MAPT protein
gentiopicroside analog inhibits the reaction [Galactose results in increased expression of MAPT protein]		 CTD PMID:36878094 NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334 		JBrowse link
G MFN2 mitofusin 2 increases expression
multiple interactions		 EXP
ISO		 Galactose results in increased expression of MFN2 protein
MIR34A mRNA promotes the reaction [Galactose results in increased expression of MFN2 protein]		 CTD PMID:28302704 NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211 		JBrowse link
G MIR34A microRNA 34a multiple interactions
increases expression		 EXP
ISO		 MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of DNM1L protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of MFN2 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of SQSTM1 protein]
Galactose results in increased expression of MIR34A mRNA		 CTD PMID:28302704 NCBI chr 1:9,151,668...9,151,777
Ensembl chr 1:9,151,668...9,151,777 		JBrowse link
G MMP2 matrix metallopeptidase 2 multiple interactions
increases activity		 ISO Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased activity of MMP2 protein] CTD PMID:30367734 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691 		JBrowse link
G MMP9 matrix metallopeptidase 9 multiple interactions
decreases expression		 ISO agomelatine inhibits the reaction [Galactose results in decreased expression of MMP9 protein]; Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of and results in increased activity of MMP9 protein]; Galactose results in increased expression of and results in increased activity of MMP9 protein; Melatonin inhibits the reaction [Galactose results in decreased expression of MMP9 protein] CTD PMID:30367734 PMID:34673010 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561 		JBrowse link
G MT-CO1 mitochondrially encoded cytochrome c oxidase I multiple interactions ISO [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of COX1 protein CTD PMID:25997894 NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445 		JBrowse link
G MT-ND4 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 affects metabolic processing EXP ND4 protein affects the metabolism of Galactose CTD PMID:8662757 NCBI chr MT:10,760...12,137
Ensembl chr MT:10,760...12,137 		JBrowse link
G MT-ND6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 affects metabolic processing ISO ND6 protein affects the metabolism of Galactose CTD PMID:9707444 NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673 		JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor multiple interactions ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of MYD88 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of MYD88 protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of MYD88 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of MYD88 mRNA]		 CTD PMID:23535186 PMID:29405769 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024 		JBrowse link
G NDUFB8 NADH:ubiquinone oxidoreductase subunit B8 multiple interactions ISO [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of NDUFB8 protein CTD PMID:25997894 NCBI chr10:100,523,729...100,529,923
Ensembl chr10:100,523,740...100,530,000 		JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 affects localization
decreases expression
multiple interactions		 ISO Galactose affects the localization of NFE2L2 protein
Galactose results in decreased expression of NFE2L2 mRNA; Galactose results in decreased expression of NFE2L2 protein
albicanol inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA]; albicanol inhibits the reaction [Galactose results in decreased expression of NFE2L2 protein]; theaflavin-3,3'-digallate inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA]
Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein]		 CTD PMID:25892055 PMID:33761044 PMID:36638877 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756 		JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 increases expression
multiple interactions		 ISO Galactose results in increased expression of NFKB1 mRNA; Galactose results in increased expression of NFKB1 protein
Galactose promotes the reaction [sodium arsenite results in increased expression of NFKB1 mRNA]		 CTD PMID:22687555 PMID:35259467 NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302 		JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions
increases expression
increases activity		 ISO Oligopeptides inhibits the reaction [Galactose results in increased activity of NOS2 protein]
Galactose results in increased expression of NOS2 mRNA		 CTD PMID:23796539 PMID:28974442 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G NOTCH1 notch receptor 1 multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of NOTCH1 protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of NOTCH1 protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of NOTCH1 protein] CTD PMID:35537655 NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048 		JBrowse link
G NOX4 NADPH oxidase 4 multiple interactions
increases expression		 ISO agomelatine inhibits the reaction [Galactose results in increased expression of NOX4 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of NOX4 protein] CTD PMID:34673010 NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 multiple interactions
decreases expression		 ISO Saponins inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA]
albicanol inhibits the reaction [Galactose results in decreased expression of NQO1 protein]; Lycopene inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA]		 CTD PMID:25892055 PMID:28974442 PMID:33761044 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668 		JBrowse link
G OAT ornithine aminotransferase multiple interactions ISO Galactose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] CTD PMID:2827574 NCBI chr10:124,397,303...124,418,923
Ensembl chr10:124,397,303...124,418,976 		JBrowse link
G OCLN occludin decreases expression ISO Galactose results in decreased expression of OCLN protein CTD PMID:33516661 NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104 		JBrowse link
G PDK1 pyruvate dehydrogenase kinase 1 multiple interactions EXP Galactose affects the reaction [Fusaric Acid results in increased expression of PDK1 protein] CTD PMID:31654802 NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669 		JBrowse link
G PKM pyruvate kinase M1/2 multiple interactions EXP Galactose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA] CTD PMID:31654802 NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819 		JBrowse link
G PLAU plasminogen activator, urokinase multiple interactions
increases expression		 ISO Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of PLAU protein] CTD PMID:30367734 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496 		JBrowse link
G PPARGC1A PPARG coactivator 1 alpha decreases expression ISO Galactose results in decreased expression of PPARGC1A protein CTD PMID:28302704 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089 		JBrowse link
G PRDX2 peroxiredoxin 2 multiple interactions
decreases expression		 ISO theaflavin-3,3'-digallate inhibits the reaction [Galactose results in decreased expression of PRDX2 mRNA] CTD PMID:36638877 NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800 		JBrowse link
G PSENEN presenilin enhancer, gamma-secretase subunit multiple interactions
increases expression		 ISO gentiopicroside analog inhibits the reaction [Galactose results in increased expression of PSENEN protein] CTD PMID:36878094 NCBI chr19:35,745,651...35,747,519
Ensembl chr19:35,745,600...35,747,519 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression		 ISO Galactose results in increased expression of and results in increased activity of PTGS2 protein; lycopene inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 protein] CTD PMID:22687555 PMID:28974442 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922 		JBrowse link
G RBPJ recombination signal binding protein for immunoglobulin kappa J region multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of RBPJ protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of RBPJ protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of RBPJ protein] CTD PMID:35537655 NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions
affects localization
increases expression		 ISO
EXP		 [Galactose co-treated with Aluminum Chloride] results in increased expression of and results in increased phosphorylation of RELA protein; [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of RELA protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of and results in increased phosphorylation of RELA protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of and results in increased phosphorylation of RELA protein]; Galactose results in increased expression of and results in increased activity of RELA protein; protocatechuic acid inhibits the reaction [Galactose results in increased expression of and results in increased activity of RELA protein]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of RELA protein]
Galactose affects the localization of RELA protein
ginsenoside F1 inhibits the reaction [Galactose affects the localization of RELA protein]; SB 203580 inhibits the reaction [Galactose affects the localization of RELA protein]
Galactose results in increased expression of RELA mRNA; Galactose results in increased expression of RELA protein		 CTD PMID:22687555 PMID:23535186 PMID:29412148 PMID:35537655 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G REST RE1 silencing transcription factor decreases expression
multiple interactions		 ISO Galactose results in decreased expression of REST protein
gentiopicroside analog inhibits the reaction [Galactose results in decreased expression of REST protein]		 CTD PMID:36878094 NCBI chr 4:56,907,900...56,935,844
Ensembl chr 4:56,907,876...56,966,808 		JBrowse link
G RNF31 ring finger protein 31 multiple interactions ISO [Lipopolysaccharides co-treated with Galactose] results in increased expression of RNF31 protein; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein] CTD PMID:34416243 NCBI chr14:24,146,875...24,160,655
Ensembl chr14:24,146,683...24,160,660 		JBrowse link
G SIRT1 sirtuin 1 multiple interactions
decreases expression		 ISO
EXP		 Saponins inhibits the reaction [Galactose results in decreased expression of SIRT1 protein]
[Glucose deficiency co-treated with Galactose co-treated with Amino Acids co-treated with Pyruvic Acid] inhibits the reaction [resveratrol results in increased expression of SIRT1 protein]		 CTD PMID:25892055 PMID:27358235 PMID:29426000 NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390 		JBrowse link
G SLC2A2 solute carrier family 2 member 2 increases transport EXP SLC2A2 protein results in increased transport of Galactose CTD PMID:8457197 NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743 		JBrowse link
G SLC2A3 solute carrier family 2 member 3 multiple interactions
increases transport		 EXP Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose]; Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose] CTD PMID:8457197 NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007 		JBrowse link
G SLC5A1 solute carrier family 5 member 1 multiple interactions
affects transport		 EXP Galactose inhibits the reaction [[Sodium co-treated with SLC5A1 protein] results in increased uptake of methylglucoside]
SLC5A1 protein affects the transport of Galactose		 CTD PMID:16300400 PMID:17288452 NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029 		JBrowse link
G SOD1 superoxide dismutase 1 decreases expression
multiple interactions		 ISO Galactose results in decreased expression of SOD1 mRNA
theaflavin-3,3'-digallate inhibits the reaction [Galactose results in decreased expression of SOD1 mRNA]		 CTD PMID:36638877 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931 		JBrowse link
G SOD2 superoxide dismutase 2 decreases expression
multiple interactions		 ISO Galactose results in decreased expression of SOD2 mRNA
albicanol inhibits the reaction [Galactose results in decreased expression of SOD2 protein]
Saponins inhibits the reaction [Galactose results in decreased expression of SOD2 mRNA]		 CTD PMID:25892055 PMID:33761044 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 		JBrowse link
G SORD sorbitol dehydrogenase increases expression ISO Galactose results in increased expression of SORD mRNA CTD PMID:22687555 NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185 		JBrowse link
G SP1 Sp1 transcription factor increases expression
multiple interactions		 ISO Galactose results in increased expression of SP1 protein
Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of SP1 protein]		 CTD PMID:30367734 NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446 		JBrowse link
G SQSTM1 sequestosome 1 increases expression
multiple interactions		 EXP
ISO		 Galactose results in increased expression of SQSTM1 protein
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]]
Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]]; Metformin inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of SQSTM1 protein]		 CTD PMID:28302704 PMID:29426000 PMID:36792013 NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078 		JBrowse link
G SREBF1 sterol regulatory element binding transcription factor 1 increases expression ISO Galactose results in increased expression of SREBF1 mRNA CTD PMID:10913129 NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002 		JBrowse link
G TFAM transcription factor A, mitochondrial multiple interactions ISO [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of TFAM protein CTD PMID:25997894 NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220 		JBrowse link
G TFEB transcription factor EB affects localization
multiple interactions		 ISO Galactose affects the localization of TFEB protein
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose affects the localization of TFEB protein]		 CTD PMID:36792013 NCBI chr 6:41,683,978...41,736,223
Ensembl chr 6:41,683,978...41,736,259 		JBrowse link
G TGFB1 transforming growth factor beta 1 increases expression
multiple interactions		 ISO Galactose results in increased expression of TGFB1 protein
Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of TGFB1 protein]		 CTD PMID:30367734 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922 		JBrowse link
G TICAM1 TIR domain containing adaptor molecule 1 multiple interactions ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TICAM1 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TICAM1 protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of TICAM1 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TICAM1 mRNA]		 CTD PMID:23535186 PMID:29405769 NCBI chr19:4,815,932...4,831,712
Ensembl chr19:4,815,932...4,831,712 		JBrowse link
G TJP1 tight junction protein 1 decreases expression
multiple interactions		 ISO Galactose results in decreased expression of TJP1 protein
Ethanol promotes the reaction [Galactose results in decreased expression of TJP1 protein]		 CTD PMID:33516661 NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915 		JBrowse link
G TLR2 toll like receptor 2 multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of TLR2 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TLR2 mRNA] CTD PMID:29405769 NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260 		JBrowse link
G TLR4 toll like receptor 4 multiple interactions ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TLR4 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TLR4 protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of TLR4 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TLR4 mRNA]		 CTD PMID:23535186 PMID:29405769 NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735 		JBrowse link
G TNF tumor necrosis factor multiple interactions
increases expression
increases secretion		 ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein; [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein; [Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein; albicanol inhibits the reaction [Galactose results in increased expression of TNF mRNA]; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein]; catalpol inhibits the reaction [Galactose results in increased expression of TNF protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein]; Lycopene inhibits the reaction [Galactose results in increased expression of TNF protein]; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of TNF protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein; candesartan inhibits the reaction [Galactose results in increased expression of TNF mRNA]; Galactose promotes the reaction [sodium arsenite results in increased expression of TNF mRNA]; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein]
Galactose results in increased expression of TNF mRNA; Galactose results in increased expression of TNF protein		 CTD PMID:22687555 PMID:23535186 PMID:23612000 PMID:28974442 PMID:29405769 More... NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TNFAIP3 TNF alpha induced protein 3 multiple interactions ISO [Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein] CTD PMID:34416243 NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314 		JBrowse link
G TP53 tumor protein p53 multiple interactions
increases expression		 EXP
ISO		 Phycocyanin inhibits the reaction [Galactose results in increased expression of TP53 protein]
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]		 CTD PMID:23036742 PMID:25997894 PMID:29426000 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538 		JBrowse link
G TXNIP thioredoxin interacting protein increases expression
multiple interactions		 EXP Galactose results in increased expression of TXNIP protein
Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]]; Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]		 CTD PMID:29426000 NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579 		JBrowse link
G TXNRD1 thioredoxin reductase 1 decreases expression
multiple interactions		 EXP Galactose results in decreased expression of TXNRD1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in decreased expression of TXNRD1 mRNA]		 CTD PMID:23274001 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307 		JBrowse link
1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CXCL10 C-X-C motif chemokine ligand 10 increases expression EXP KRN 7000 results in increased expression of CXCL10 protein CTD PMID:15867097 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497 		JBrowse link
G IL12B interleukin 12B increases expression EXP KRN 7000 results in increased expression of IL12B protein CTD PMID:15867097 NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863 		JBrowse link
alpha-D-galactose 1-phosphate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GALK1 galactokinase 1 multiple interactions EXP [Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate CTD PMID:20696150 NCBI chr17:75,751,469...75,765,192
Ensembl chr17:75,751,594...75,765,236 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26041
    role 25957
      biological role 25936
        biochemical role 25170
          metabolite 25100
            fundamental metabolite 15686
              galactose 210
                D-galactose 210
                  D-galactopyranose 210
                    alpha-D-galactose 119
                      1-O-(4-O-\{3-[4-(trifluoromethyl)phenyl]propyl\}-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-allyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-benzyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-propyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(6-acetamido-6-deoxy-alpha-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(10-phenyldecanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(11-phenylundecanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(21-phenylhenicosanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(25-phenylpentacosanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(6-phenylhexanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(7-phenylheptanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(9-phenylnonanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[11-(4-fluorophenyl)undecanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[11-(4-methoxyphenyl)undecanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[6-(4-methoxyphenyl)hexanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-fluorophenyl)octanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-methoxyphenyl)octanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-trifluoromethyl)phenyloctanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-\{11-[4-(trifluoromethyl)phenyl]undecanoyl\}phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-\{6-[4-(trifluoromethyl)phenyl]hexanoyl\}phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-dodecanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylsphinganine 0
                      1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-nonanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-octanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-pamitoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetracosanylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetradecanoylphytosphingosine 0
                      1-O-(alpha-D-galactosyl)-N-decanoylphytosphingosine 0
                      1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine + 2
                      1-O-(alpha-D-galactosyl)-N-undecanoylphytosphingosine 0
                      1-O-[4-O-(2-adamantylethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3,4-dichlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3,4-difluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3-phenylpropyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-chlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-fluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-methylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-phenylbutyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-tert-butylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(5-phenylpentyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(6-phenylhexyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(cyclobutylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(cyclopropylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylsphinganine 0
                      1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(3,4-dichlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-chlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-methoxyphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-methylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-tert-butylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      2-deoxy-2-fluoro-alpha-D-galactose 0
                      GlcpN-(1->1)-alpha-D-Galp 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-13-phenyltridecan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-8-phenyloctan-2-yl]hexacosanamide 0
                      N-[11-([1,1'-biphenyl]-4-yl)undecanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[6-(4-fluorophenyl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[6-([1,1'-biphenyl]-4-yl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[8-([1,1'-biphenyl]-4-yl)octanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      alpha-D-Gal-(1->3)-alpha-D-Gal-OMe 0
                      alpha-D-Gal-(1->4)-alpha-D-Gal-OMe 0
                      alpha-D-Galf-(1->2)-alpha-D-Galp 0
                      alpha-D-Galp-(1->2)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->2)-alpha-D-Manp 0
                      alpha-D-Galp-(1->2)-beta-D-Glcp-(1->4)-beta-D-Glcp 0
                      alpha-D-Galp-(1->2)-beta-D-Manp 0
                      alpha-D-Galp-(1->3)-D-GalNAc-OH 0
                      alpha-D-Galp-(1->3)-D-Glcp 0
                      alpha-D-Galp-(1->3)-alpha-D-GlcpNAc 0
                      alpha-D-Galp-(1->3)-alpha-D-Manp 0
                      alpha-D-Galp-(1->3)-beta-D-GlcpNAc + 0
                      alpha-D-Galp-(1->4)-D-Gal-OH 0
                      alpha-D-Galp-(1->4)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->4)-alpha-L-Fucp 0
                      alpha-D-Galp-(1->4)-beta-D-Glcp + 0
                      alpha-D-Galp-(1->4)-beta-D-GlcpNAc 0
                      alpha-D-Galp-(1->6)-D-Glc-OH 0
                      alpha-D-Galp-(1->6)-alpha-D-Galp 0
                      alpha-D-Galp-(1->6)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->6)-beta-D-Manp 0
                      alpha-D-GalpNAc-(1->3)-alpha-D-Galp + 0
                      alpha-D-Glcp-(1->3)-alpha-D-Galp + 0
                      alpha-D-Glcp-(1->6)-D-Gal-OH 0
                      alpha-D-Glcp-(1->6)-alpha-D-Galp + 0
                      alpha-D-GlcpN-(1->1)-alpha-D-Galp 0
                      alpha-D-Manp-(1->2)-alpha-D-Galp 0
                      alpha-D-galactose 1-phosphate 1
                      alpha-D-galactoside + 0
                      alpha-D-galactosyl group + 0
                      alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1<->1')-ceramide 0
                      alpha-L-Fucp-(1->2)-alpha-D-Galp 0
                      alpha-L-Fucp-(1->3)-alpha-D-Galp + 0
                      alpha-L-Fucp-(1->6)-alpha-D-Galp 0
                      beta-D-Galf-(1->3)-alpha-D-Galp 0
                      beta-D-Glcp-(1->3)-alpha-D-Galp 0
                      beta-D-Glcp-(1->6)-alpha-D-Galp 0
                      beta-D-GlcpNAc-(1->2-)alpha-D-Galp 0
                      beta-L-Fucp-(1->2)-alpha-D-Galp 0
                      beta-L-Fucp-(1->3)-alpha-D-Galp 0
                      beta-L-Fucp-(1->4)-alpha-D-Galp + 0
                      penta-O-acetyl-alpha-D-galactose 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 26041
    subatomic particle 26016
      composite particle 26016
        hadron 26016
          baryon 26016
            nucleon 26016
              atomic nucleus 26016
                atom 26016
                  main group element atom 25841
                    p-block element atom 25841
                      carbon group element atom 25441
                        carbon atom 25399
                          organic molecular entity 25399
                            heteroorganic entity 24773
                              organochalcogen compound 24384
                                organooxygen compound 24061
                                  carbohydrates and carbohydrate derivatives 16791
                                    carbohydrate 16791
                                      monosaccharide 4980
                                        aldose 3333
                                          aldohexose 2958
                                            D-aldohexose 2950
                                              D-galactose 210
                                                D-galactopyranose 210
                                                  alpha-D-galactose 119
                                                    1-O-(4-O-\{3-[4-(trifluoromethyl)phenyl]propyl\}-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-allyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-benzyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-propyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(6-acetamido-6-deoxy-alpha-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(10-phenyldecanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(11-phenylundecanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(21-phenylhenicosanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(25-phenylpentacosanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(6-phenylhexanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(7-phenylheptanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(9-phenylnonanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[11-(4-fluorophenyl)undecanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[11-(4-methoxyphenyl)undecanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[6-(4-methoxyphenyl)hexanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-fluorophenyl)octanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-methoxyphenyl)octanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-trifluoromethyl)phenyloctanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-\{11-[4-(trifluoromethyl)phenyl]undecanoyl\}phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-\{6-[4-(trifluoromethyl)phenyl]hexanoyl\}phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-dodecanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylsphinganine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-nonanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-octanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-pamitoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetracosanylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetradecanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactosyl)-N-decanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine + 2
                                                    1-O-(alpha-D-galactosyl)-N-undecanoylphytosphingosine 0
                                                    1-O-[4-O-(2-adamantylethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3,4-dichlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3,4-difluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3-phenylpropyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-chlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-fluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-methylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-phenylbutyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-tert-butylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(5-phenylpentyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(6-phenylhexyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(cyclobutylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(cyclopropylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylsphinganine 0
                                                    1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(3,4-dichlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-chlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-methoxyphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-methylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-tert-butylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    2-deoxy-2-fluoro-alpha-D-galactose 0
                                                    GlcpN-(1->1)-alpha-D-Galp 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-13-phenyltridecan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-8-phenyloctan-2-yl]hexacosanamide 0
                                                    N-[11-([1,1'-biphenyl]-4-yl)undecanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[6-(4-fluorophenyl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[6-([1,1'-biphenyl]-4-yl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[8-([1,1'-biphenyl]-4-yl)octanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    alpha-D-Gal-(1->3)-alpha-D-Gal-OMe 0
                                                    alpha-D-Gal-(1->4)-alpha-D-Gal-OMe 0
                                                    alpha-D-Galf-(1->2)-alpha-D-Galp 0
                                                    alpha-D-Galp-(1->2)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->2)-alpha-D-Manp 0
                                                    alpha-D-Galp-(1->2)-beta-D-Glcp-(1->4)-beta-D-Glcp 0
                                                    alpha-D-Galp-(1->2)-beta-D-Manp 0
                                                    alpha-D-Galp-(1->3)-D-GalNAc-OH 0
                                                    alpha-D-Galp-(1->3)-D-Glcp 0
                                                    alpha-D-Galp-(1->3)-alpha-D-GlcpNAc 0
                                                    alpha-D-Galp-(1->3)-alpha-D-Manp 0
                                                    alpha-D-Galp-(1->3)-beta-D-GlcpNAc + 0
                                                    alpha-D-Galp-(1->4)-D-Gal-OH 0
                                                    alpha-D-Galp-(1->4)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->4)-alpha-L-Fucp 0
                                                    alpha-D-Galp-(1->4)-beta-D-Glcp + 0
                                                    alpha-D-Galp-(1->4)-beta-D-GlcpNAc 0
                                                    alpha-D-Galp-(1->6)-D-Glc-OH 0
                                                    alpha-D-Galp-(1->6)-alpha-D-Galp 0
                                                    alpha-D-Galp-(1->6)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->6)-beta-D-Manp 0
                                                    alpha-D-GalpNAc-(1->3)-alpha-D-Galp + 0
                                                    alpha-D-Glcp-(1->3)-alpha-D-Galp + 0
                                                    alpha-D-Glcp-(1->6)-D-Gal-OH 0
                                                    alpha-D-Glcp-(1->6)-alpha-D-Galp + 0
                                                    alpha-D-GlcpN-(1->1)-alpha-D-Galp 0
                                                    alpha-D-Manp-(1->2)-alpha-D-Galp 0
                                                    alpha-D-galactose 1-phosphate 1
                                                    alpha-D-galactoside + 0
                                                    alpha-D-galactosyl group + 0
                                                    alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1<->1')-ceramide 0
                                                    alpha-L-Fucp-(1->2)-alpha-D-Galp 0
                                                    alpha-L-Fucp-(1->3)-alpha-D-Galp + 0
                                                    alpha-L-Fucp-(1->6)-alpha-D-Galp 0
                                                    beta-D-Galf-(1->3)-alpha-D-Galp 0
                                                    beta-D-Glcp-(1->3)-alpha-D-Galp 0
                                                    beta-D-Glcp-(1->6)-alpha-D-Galp 0
                                                    beta-D-GlcpNAc-(1->2-)alpha-D-Galp 0
                                                    beta-L-Fucp-(1->2)-alpha-D-Galp 0
                                                    beta-L-Fucp-(1->3)-alpha-D-Galp 0
                                                    beta-L-Fucp-(1->4)-alpha-D-Galp + 0
                                                    penta-O-acetyl-alpha-D-galactose 0
paths to the root